Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 52 citing Cordonnier: Should immunoglobulin therapy be used in allogeneic stem-cell transplantation?.... (0.11 sec) 

Use of intravenous immunoglobulin in human disease: a review of evidence by members of …

- aaaai.org [PDF] 
JS Orange, EM Hossny, CR Weiler, M Ballow, … - The Journal of Allergy and Clinical Immunology, 2006 - Elsevier
Over the past 2½ decades, administration of exogenous pooled human
immunoglobulin for intravenous use (IGIV; commonly referred to as IVIG, although
licensed in the United States as IGIV) has become an important therapy in ...
Cited by 100 - Related articles - All 28 versions

Ancillary therapy and supportive care of chronic graft-versus-host disease: national …


D Couriel, PA Carpenter, C Cutler, J … - Biology of Blood and Marrow Transplantation, 2006 - Elsevier
The Ancillary Therapy and Supportive Care Working Group had 3 goals: (1) to
establish guidelines for ancillary therapy and supportive care in chronic
graft-versus-host disease (GVHD), including treatment for symptoms and ...
Cited by 60 - Related articles - BL Direct - All 9 versions

Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts …


K Darabi, O Abdel-Wahab, WH Dzik - Transfusion, 2006 - prsjournal.org
Harvard University Joint Program in Transfusion Medicine, Boston, Massachusetts;
and the Blood Transfusion Service and the Department of Medicine, Massachusetts
General Hospital, Boston, Massachusetts. ... Address reprint requests to: ...
Cited by 45 - Related articles - Cached - BL Direct - All 6 versions

Immune restoration following hematopoietic stem cell transplantation: an evolving target


JJ Auletta, HM Lazarus - Bone marrow transplantation, 2005 - nature.com
Hematopoietic stem cell transplantation (HSCT) is the definitive cure for many
malignant and nonmalignant diseases. However, delays in immune reconstitution
(IR) following HSCT significantly limit the success of transplantation and ...
Cited by 42 - Related articles - All 5 versions

Intravenous immunoglobulin: an update on the clinical use and mechanisms of action


VS Negi, S Elluru, S SibERil, SEP Graff- … - Journal of clinical immunology, 2007 - Springer
Page 1. Journal of Clinical Immunology, Vol. 27, No. 3, May 2007 ( C 2007) DOI:
10.1007/s10875-007-9088-9 Intravenous Immunoglobulin: An Update on the Clinical ...
Cited by 34 - Related articles - BL Direct - All 4 versions

IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock …


M Hentrich, K Fehnle, H Ostermann, J Kienast … - Critical care medicine, 2006 - pdfs.journals.lww.com
Objective: To evaluate the effect of intravenous IgMA-enriched immunoglobulin
(ivIGMA) therapy on mortality in neutropenic patients with hematologic
malignancies and sepsis syndrome or septic shock. Design: Multiple-center, ...
Cited by 31 - Related articles - BL Direct - All 11 versions

Guidelines on the use of intravenous immune globulin for hematologic conditions


D Anderson, K Ali, V Blanchette, M Brouwers … - Transfusion Medicine Reviews, 2007 - Elsevier
Canada's per capita use of intravenous immune globulin (IVIG) grew by
approximately 115% between 1998 and 2006, making Canada one of the world's
highest per capita users of IVIG. It is believed that most of this growth ...
Cited by 28 - Related articles - All 7 versions

Association of neurocognitive function and quality of life 1 year after coronary artery bypass …

- spb.ru
B Phillips-Bute, JP Mathew, JA Blumenthal, … - Psychosomatic medicine, 2006 - Am Psychosomatic Soc
Methods: With Institutional Review Board (IRB) approval and written informed
consent, 732 patients at Duke University Hospital undergoing CABG were enrolled.
Five hundred fifty-one (75%) completed baseline, 6-week, and 1-year ...
Cited by 25 - Related articles - BL Direct - All 7 versions

Redox regulation in anabolic and catabolic processes


W Dröge - Current Opinion in Clinical Nutrition & Metabolic Care, 2006 - journals.lww.com
Recent findings: The redox-sensitive transcription factors nuclear factor κB
and activator protein 1 facilitate ubiquitin-proteasome-dependent proteolysis.
Nuclear factor κB also plays a role in induced expression of tumor ...
Cited by 20 - Related articles - BL Direct - All 7 versions

Platelet transfusion containing ABO-incompatible plasma and hepatic veno-occlusive disease …


V Lapierre, C Mahé, A Aupérin, F Stambouli … - Transplantation, 2005 - journals.lww.com
The prognosis of children with solid tumors has consider- ably improved over the
last 20 years. Such an improve- ment is mainly due to the chemosensitivity of
pediatric tu- mors, which distinguishes them from most adult tumors. Given ...
Cited by 18 - Related articles - BL Direct - All 3 versions


Result Page: 

1

2

3

4

5

6

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google